MedTrace Logo

Split Scar Study to Assess Cosmetic Outcome From Differing Suture Spacing

NCT03284983 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-09-15

No results posted yet for this study

Summary

The investigators wish to determine how suture spacing (5 mm vs. 10 mm) affects cosmetic outcome and development of "train tracking" in wounds. Linear wounds with sutures spaced closer together may not be as cosmetically appealing when compared to those that have larger spacing between sutures. Suturing closer together constricts blood flow and increases tension that ultimately results in more tissue necrosis and a less appealing outcome. The investigators also aim to conclude if 5 mm or 10 mm suture spacing results in less complications.

Conditions

  • Suture, Complication
  • Wound
  • Wound Complication
  • Wound Dehiscence
  • Wound of Skin
  • Surgery
  • Suture; Complications, Infection or Inflammation

Interventions

OTHER

Suture spacing for wound closure

The wound was divided in half and sutures were spaced 5mm or 10mm apart depending on side. The sutures were removed at 2-week follow-up appointment and photographs were taken. The Patient and Observer Scar Assessment Scale (POSAS) was then performed by both patient and physician.

Sponsors & Collaborators

  • Samaritan Health Services

    collaborator OTHER

  • Silver Falls Dermatology

    lead OTHER

Principal Investigators

  • William Lear, MD · Silver Falls Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2017-10-01
Completion
2017-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03284983 on ClinicalTrials.gov